Vivoryon (ex Probiodrug) ist ein Biotech-Unternehmen, dessen Schwerpunkt auf der Entwicklung neuer Therapieansätze für die Behandlung von Alzheimer liegt. Der Firmensitz befindet sich in Halle/Saale, gelistet ist die Gesellschaft jedoch an der Euronext.

COMPANY

Vivoryon Therapeutics

INVESTOR TERMSHEET

#BGFL app

#BGFL Publisher

05Y

#BGFL Mood: Negative · #BGFL-Indicator: Reduce · Review date: -

LEI: 3912004AMB0KGZXZYJ15

SECTOR: Gesundheit SUB-SECTOR: Biotechnologie

NAME

Vivoryon Therapeutics

WKN

A2QJV6

ISIN

NL00150002Q7

TICKER

05Y

INDEX

EXCHANGE

Xetra

BUY SELL

Made with ❤ von BGFL

#BGFL

Newswire

Ratings

#BGFL-nes Vivoryon Therapeutics: boersengefluester.de (BGFL) regularly writes extensive editorial articles for most of the companies in our database - especially those in the special stocks sector. Here we show you a list of the most recent articles by BGFL on the selected share.

No data

Newswire Vivoryon Therapeutics: Official company news is an enormously important source of information for investors - especially if it is particularly price-sensitive and therefore subject to ad hoc disclosure. Here we show the reports provided by the IR portal EQS News on companies from the BGFL coverage universe.

07.03.2022	DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference

Resaerch for Vivoryon Therapeutics: Independent research is hard to find, especially in the speciality stocks sector. However, there are a number of firms that regularly produce meaningful analyses of the companies they cover. As a rule, this is paid research - but the analyses are definitely worth reading.

No data

The #BGFL Coverage App Gallery

Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.

Corporate Name Change

Financial Calendar

Interviews, Quotes, Analyses

IR-Quick Check

Annual Reports

Does news drive share prices or does the chain of effects run the other way round - as is often assumed? Well, at boersengefluester.de we offer you all kinds of ways to follow daily stock market events. Take a look at our apps on the subject of news.

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.

Vivoryon Therapeutics

Quick Links

Network

Partner

Contact

Vivoryon Therapeutics

Would you like to see fewer adverts? Simply register for a user account. Registration is free and significantly reduces the number of adverts.

Quick Links

Network

Partner

Contact